24 November 2021 Ad-hoc Announcement: Achiko’s Covid-19 DNA aptamer-based rapid testing platform update
27 October 2021 Ad-hoc Announcement: Achiko secures initial sales of AptameX Covid-19 diagnostic test
27 September 2021 Ad-hoc Announcement: Achiko AG reports first half to 30 June 2021 results and provides corporate update
25 August 2021 Ad-hoc Announcement: Achiko’s rapid Covid-19 diagnostic test AptameX™ receives product and registration approval from Indonesia’s Ministry of Health
15 July 2021 Ad-hoc Announcement: Achiko engages EpiMetrics to expand Covid-19 testing operations with Udayana University in Bali, Indonesia in the implementation of a mass testing program
3 June 2021 Achiko announces the successful integration of its Teman Sehat digital ecosystem and AptameX Covid-19 diagnostic testing platform for launch in Indonesia
20 May 2021 Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads
29 April 2021 Achiko’s joint venture partner obtains a distribution certificate for AptameX, a novel diagnostic test for Covid-19 in Indonesia, and commences product registration
12 February 2021 Achiko establishes a joint venture with PT Indonesia Farma Medis for the production and distribution of its test platform for Covid-19 in Indonesia
11 February 2021 2021 Extraordinary Shareholders’ Meeting of Achiko AG: shareholders adopt all proposals
19 January 2021 Achiko AG invites shareholders to an Extraordinary Shareholders’ Meeting on 11 February 2021